<?xml version="1.0" encoding="UTF-8"?><!DOCTYPE us-patent-application SYSTEM "us-patent-application-v43-2012-12-04.dtd" [ ]><us-patent-application lang="EN" dtd-version="v4.3 2012-12-04" file="US20140004106A1-20140102.XML" status="PRODUCTION" id="us-patent-application" country="US" date-produced="20131218" date-publ="20140102"><us-bibliographic-data-application lang="EN" country="US"><publication-reference><document-id><country>US</country><doc-number>20140004106</doc-number><kind>A1</kind><date>20140102</date></document-id></publication-reference><application-reference appl-type="utility"><document-id><country>US</country><doc-number>13850849</doc-number><date>20130326</date></document-id></application-reference><us-application-series-code>13</us-application-series-code><classifications-ipcr><classification-ipcr><ipc-version-indicator><date>20060101</date></ipc-version-indicator><classification-level>A</classification-level><section>A</section><class>61</class><subclass>K</subclass><main-group>39</main-group><subgroup>395</subgroup><symbol-position>F</symbol-position><classification-value>I</classification-value><action-date><date>20140102</date></action-date><generating-office><country>US</country></generating-office><classification-status>B</classification-status><classification-data-source>H</classification-data-source></classification-ipcr></classifications-ipcr><classifications-cpc><main-cpc><classification-cpc><cpc-version-indicator><date>20130101</date></cpc-version-indicator><section>A</section><class>61</class><subclass>K</subclass><main-group>39</main-group><subgroup>39558</subgroup><symbol-position>F</symbol-position><classification-value>I</classification-value><action-date><date>20140102</date></action-date><generating-office><country>US</country></generating-office><classification-status>B</classification-status><classification-data-source>H</classification-data-source><scheme-origination-code>C</scheme-origination-code></classification-cpc></main-cpc></classifications-cpc><classification-national><country>US</country><main-classification>4241331</main-classification><further-classification>4241581</further-classification><further-classification>4241731</further-classification></classification-national><invention-title id="d0e43">STABLE IGG4 BASED BINDING AGENT FORMULATIONS</invention-title><us-related-documents><us-provisional-application><document-id><country>US</country><doc-number>61615539</doc-number><date>20120326</date></document-id></us-provisional-application></us-related-documents><us-parties><us-applicants><us-applicant sequence="00" app-type="applicant" designation="us-only"><addressbook><last-name>Sanofi</last-name><address><country>US</country></address></addressbook><residence><country>US</country></residence></us-applicant></us-applicants><inventors><inventor sequence="00" designation="us-only"><addressbook><last-name>SCHNIEDERS</last-name><first-name>Julia</first-name><address><city>Frankfurt</city><country>DE</country></address></addressbook></inventor><inventor sequence="01" designation="us-only"><addressbook><last-name>USENER</last-name><first-name>Dirk</first-name><address><city>Frankfurt</city><country>DE</country></address></addressbook></inventor><inventor sequence="02" designation="us-only"><addressbook><last-name>RUGGEBERG</last-name><first-name>Sabrina</first-name><address><city>Frankfurt</city><country>DE</country></address></addressbook></inventor><inventor sequence="03" designation="us-only"><addressbook><last-name>YOUSSEF</last-name><first-name>Ahmed</first-name><address><city>Frankfurt</city><country>DE</country></address></addressbook></inventor><inventor sequence="04" designation="us-only"><addressbook><last-name>KIRSCH</last-name><first-name>Martina</first-name><address><city>Frankfurt</city><country>DE</country></address></addressbook></inventor></inventors></us-parties><assignees><assignee><addressbook><orgname>Sanofi</orgname><role>03</role><address><city>Paris</city><country>FR</country></address></addressbook></assignee></assignees></us-bibliographic-data-application><abstract id="abstract"><p id="p-0001" num="0000">The present invention provides stable pharmaceutical antibody formulations, including liquid drug product formulations and lyophilized drug product formulations, comprising an IgG4 binding agent and a citrate buffer, wherein the pH of the formulation is at or below both pH 6 and the pI of the binding agent. The formulations can be used in the treatment of chronic bowel diseases or rheumatoid arthritis.</p></abstract></us-patent-application>